Abstract Symposia Tuesday
Tuesday, July 2, 13.00-14.15
AS-13: Role of FXII activation in mechanism of thrombosis
- Factor XII: what’s new?
Nicola Mutch
AS-14: Methods and relevance of microparticle detection
- Microparticle detection: why and how?
Paul Harrison
AS-15: New approaches to antiplatelet therapy
- Clinical use of purinergic receptor blockers
Richard Becker
AS-16: Functional characterisation of hereditary platelet disorders
- Genetics, platelet dysfunction and bleeding
Kathleen Freson
AS-17: Challenges in therapeutic management of VTE
- Aspirin for the prevention and treatment of venous thromboembolism
Cecilia Becattini
AS-18: Prevention of recurrent VTE
- Management and prognosis after a first venous thrombosis
Sabine Eichinger
AS-19: Vascular disorders
- Chronic thromboembolic pulmonary hypertension – a model disease for vascular occlusion
Irene Lang
AS-20: New developments in treatment of VTE
- New anticoagulants for venous thrombosis: opportunities and challenges
Jeffrey Weitz
AS-21: The interplay between coaulation and inflammation
- Tissue factor signaling and inflammation
Wolfram Ruf
AS-22: Inhibitors in Haemophilia A
- Haemophilia inhibitors
Anske van der Bom
AS-23: What’s new in fibrinolysis?
- Plasminogen activator inhibitor-1: what’s new?
Douglas Vaughan
AS-24: Pleiotropic effects of fibrinogen
- A possible role for Fibrin in Alzheimer’s disease
Sidney Strickland